| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 147 / 151 | 2nd | Q4 |
| Oncology | 418 / 428 | 2nd | Q4 |
| Cancer Research | 230 / 233 | 1st | Q4 |
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Leukemia and Lymphoma
Journal of Leukemia and Lymphoma is Scopus-indexed (Q4, CiteScore 0.1). Published by Chinese Medical Journals Publishing House Co.Ltd.
Checked against the index lists dated .
ISSN 1009-9921Verify ISSN ↗
Publisher: Chinese Medical Journals Publishing House Co.Ltd
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Journal of Leukemia and Lymphoma indexed in Scopus?
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q4, CiteScore 0.1.
What quartile is Journal of Leukemia and Lymphoma in Scopus?
Journal of Leukemia and Lymphoma is Q4 in Hematology (rank 147 of 151), Q4 in Oncology (rank 418 of 428) and Q4 in Cancer Research (rank 230 of 233), by CiteScore 2025.
What is the impact factor of Journal of Leukemia and Lymphoma?
Journal of Leukemia and Lymphoma is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.1, quartile Q4, 2nd percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.106, quartile Q4, with an H-index of 6.
Who publishes Journal of Leukemia and Lymphoma and what is its ISSN?
Journal of Leukemia and Lymphoma is published by Chinese Medical Journals Publishing House Co.Ltd. Its ISSN is 1009-9921.
Is Journal of Leukemia and Lymphoma in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Journal of Leukemia and Lymphoma open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
How well cited is Journal of Leukemia and Lymphoma? — open metrics via OpenAlex
Journal of Leukemia and Lymphoma has an h-index of 2 and a 2-year mean of 0 citations per paper (OpenAlex). Its Scopus CiteScore is 0.1, quartile Q4. On 2-year citations it ranks #140 of 148 Scopus journals in Hematology.
Journal of Leukemia and Lymphoma published 28 papers in 2017; its busiest recent year was 2009 with 262. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
Are there integrity warnings for Journal of Leukemia and Lymphoma? — indicators, not proof of misconduct
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusActive
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.